Not The Way You Want To Start Your Year: Inspire Cystic Fibrosis Drug Fails Late

Denufosol, a potentially disease-altering CF drug, was headed for an NDA filing later this year based on positive Phase III TIGER-1 data, but that was before the bad news from TIGER-2.